News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Toni Choueiri: Pembrolizumab hits OVERALL SURVIVAL in KYN-564 adjuvant study in Kidney Cancer!!!
Photo from Toni Choueiri/Twitter
Nov 5, 2023, 18:48

Toni Choueiri: Pembrolizumab hits OVERALL SURVIVAL in KYN-564 adjuvant study in Kidney Cancer!!!

Toni Choueiri, the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), posted on LinkedIn.

“JUST IN (and finally…): Pembrolizumab hits OVERALL SURVIVAL in KYN-564 adjuvant study in Kidney Cancer!!!
The time has finally come… via Business Wire.”

Image preview

 

Source: Toni Choueiri/LinkedIn

cancer KEYNOTE-564 kidney cancer OncoDaily Oncology pembrolizumab Toni Choueiri
Insight
Jul 6, 2024, 10:37
Moawia Mohammed Ali Elhassan: Collapse of Cancer Care Under the Current Conflict in Sudan
Blog
Jul 6, 2024, 10:31
Congratulations to the successful SIOP Asia 2024 Congress in Yokohama, Japan
Insight
Jul 6, 2024, 10:23
Pierre Blanchard: Silke Gillessen and Bertrand Tombal, on intermittent ADT/ARPI in metastatic prostrate cancer
Insight
Jul 6, 2024, 10:11
Zainab Shinkafi-Bagudu: Great to see the team Cancer Survival Group leading a new The Lancet commission
Insight
Jul 6, 2024, 10:05
The 2025 call for EHA Grants is now open
Insight
Jul 6, 2024, 09:58
Justin Ferdinandus: BrECADD is better tolerated than eBEACOPP for patients with advanced Hodgkin Lymphoma
Blog
Jul 6, 2024, 09:48
Nicolas Hubacz: White Blood Cell's Checking for Foreign Invaders
Positive
Jul 6, 2024, 09:09
William Dahut is biking 328 miles to support Hope Lodge
Positive
Jul 6, 2024, 09:02
Incredible 2024 Survivor Scholarship awardees
Career
Jul 6, 2024, 08:53
S K Gupta: I’ve completed my Fellowship in Leukemia/BMT/CAR T-Cell at The University of British Columbia
Insight
Jul 6, 2024, 08:14
Aline Pfefferle: Our pan-cancer human NK cell atlas
Drugs
Jul 6, 2024, 07:58
Tanja Obradovic: Important lesson in development of the PDL-1 inhibitor just came in